Table of Contents

July 19, 2005; 143 (2)

Articles

  • Cost-Effectiveness of Full Medicare Coverage of Angiotensin-Converting Enzyme Inhibitors for Beneficiaries with Diabetes

    • Allison B. Rosen,
    • Mary Beth Hamel,
    • Milton C. Weinstein,
    • David M. Cutler,
    • A. Mark Fendrick,
    • and Sandeep Vijan
    Ann Intern Med July 19, 2005 143:89-99

    The authors compared the cost-effectiveness of Medicare first-dollar coverage of angiotensin-converting enzyme inhibitors for diabetic beneficiaries with current practice (no coverage) and the new Medicare drug benefit. First-dollar coverage would extend life and reduce Medicare program costs, unlike current practice or the Medicare drug program, because it would promote greater use of a drug that prevents diabetes complications and their costs.

  • The Wells Rule Does Not Adequately Rule Out Deep Venous Thrombosis in Primary Care Patients

    • Ruud Oudega,
    • Arno W. Hoes,
    • and Karel G.M. Moons
    Ann Intern Med July 19, 2005 143:100-107

    This study aimed to validate the diagnostic accuracy of the Wells rule for deep venous thrombosis (DVT) in 1295 consecutive primary care patients with suspected DVT. Twelve percent of patients in the low-risk group had DVT (only 3%; had DVT in the original study by Wells). In low-risk people who had negative results on d-dimer tests, the prevalence of DVT was 2.9% (0.9% had DVT in the original study). The Wells rule did not accurately estimate the prevalence of DVT in low-risk primary care patients.

  • Echocardiographic Evaluation in Asymptomatic Relatives of Patients with Dilated Cardiomyopathy Reveals Preclinical Disease

    • Niall G. Mahon,
    • Ross T. Murphy,
    • Calum A. MacRae,
    • Alida L.P. Caforio,
    • Perry M. Elliott,
    • and William J. McKenna
    Ann Intern Med July 19, 2005 143:108-115

    The authors examined 767 asymptomatic relatives of 189 consecutive unselected patients with dilated cardiomyopathy. Approximately 5% had treatable asymptomatic cases of the disorder. Left ventricular enlargement or depressed fractional shortening was common and was associated with an increased medium-term risk for disease progression. Relatives of patients with cardiomyopathy need cardiac evaluation.

  • Brief Communication: The Prevalence of High Intake of Vitamin E from the Use of Supplements among U.S. Adults

    • Earl S. Ford,
    • Umed A. Ajani,
    • and Ali H. Mokdad
    Ann Intern Med July 19, 2005 143:116-120

    People who consume at least 400 IU of vitamin E per day from supplements may be at slightly increased risk for premature death. By examining data from the 1999–2000 National Health and Nutrition Examination Survey, the authors concluded that approximately 11% of U.S. adults age 20 years or older consume at least 400 IU of vitamin E per day.

Improving Patient Care

  • Patient Safety Concerns Arising from Test Results That Return after Hospital Discharge

    • Christopher L. Roy,
    • Eric G. Poon,
    • Andrew S. Karson,
    • Zahra Ladak-Merchant,
    • Robin E. Johnson,
    • Saverio M. Maviglia,
    • and Tejal K. Gandhi
    Ann Intern Med July 19, 2005 143:121-128

    Many patients are discharged from hospitals with test results still pending, and physicians are often unaware of potentially actionable findings that appear in the medical record after discharge. Health organizations need better systems for ensuring good follow-up of test results returning after hospital discharge.

Review

  • Meta-Analysis: The Value of Clinical Assessment in the Diagnosis of Deep Venous Thrombosis

    • Steve Goodacre,
    • Alex J. Sutton,
    • and Fiona C. Sampson
    Ann Intern Med July 19, 2005 143:129-139

    The authors summarized published research on the sensitivity and specificity of clinical findings, risk scores, and physicians' empirical judgments for deep venous thrombosis (DVT). Only malignancy, previous DVT, recent immobilization, difference in calf circumference, and recent surgery were useful for ruling in DVT. Only symmetry in calf circumference or absence of calf swelling was useful for ruling out DVT. Assessment of clinical probability by using the Wells score is more useful than individual clinical features.

Editorials

  • Use of a Clinical Prediction Score in Patients with Suspected Deep Venous Thrombosis: Two Steps Forward, One Step Back?

    • James D. Douketis
    Ann Intern Med July 19, 2005 143:140-142

    In this issue, 2 articles assess a low Wells score as a predictor of deep venous thrombosis (DVT). Goodacre and colleagues concluded that a low Wells score and negative results on a d-dimer test made venous ultrasonography unnecessary. In contrast, Oudega and coworkers found that 3% of patients with a low Wells score plus negative d-dimer test results had DVT. To reconcile these apparently discordant findings, we might start by considering the criteria that a clinical prediction score should satisfy before using it in everyday practice.

  • An Editorial Update: Annus horribilis for Vitamin E

    • Eliseo Guallar,
    • Daniel F. Hanley,
    • and Edgar R. Miller III
    Ann Intern Med July 19, 2005 143:143-145

    In January 2005, we published a dose–response meta-analysis showing that high-dosage (≥400 IU/d) vitamin E supplementation was associated with a small but statistically significant increased risk for death. These findings were highly controversial: This issue of Annals includes 11 of more than 40 electronic rapid-response letters about our article. Rather than summarizing this exchange of views, however, this editorial reports further developments in the vitamin E story.

  • Is This Clinical Trial Fully Registered?: A Statement from the International Committee of Medical Journal Editors*

    • Catherine D. De Angelis,
    • Jeffrey M. Drazen,
    • Frank A. Frizelle,
    • Charlotte Haug,
    • John Hoey,
    • Richard Horton,
    • Sheldon Kotzin,
    • Christine Laine,
    • Ana Marusic,
    • A. John P.M. Overbeke,
    • Torben V. Schroeder,
    • Harold C. Sox,
    • and Martin B. Van Der Weyden
    Ann Intern Med July 19, 2005 143:146-148

    In September 2004, the International Committee of Medical Journal Editors (ICMJE) published a joint editorial to promote registration of all clinical trials. We stated that we will consider a trial for publication only if it has been registered before the enrollment of the first patient. As our deadline for registration approaches, trial authors and sponsors want to be sure that they understand our requirements. The purpose of this joint editorial is to answer questions about the ICMJE initiative and to bring our position into harmony with that of others who are working toward the same end.

On Being a Doctor

  • Food for Thought

    • Sunil Badve
    Ann Intern Med July 19, 2005 143:149

    One day, working in Lokmanya Tilak Municipal General Hospital in Mumbai, India, I filled out discharge forms for one of my patients, a middle-aged worker with fever who had responded to antimalarial treatment. During evening rounds, however, I found him still sitting on the hospital bed. I was annoyed; I told the patient that he had been discharged and should leave. I left to attend to other patients, completed my evening rounds, and began to see the new admissions. Then I witnessed something unforgettable.

Letters

  • High-Dosage Vitamin E Supplementation and All-Cause Mortality

    • David H. Blatt and
    • William A. Pryor
    Ann Intern Med July 19, 2005 143:150-151

  • High-Dosage Vitamin E Supplementation and All-Cause Mortality

    • Koyamangalath Krishnan,
    • Sharon Campbell,
    • and William L. Stone
    Ann Intern Med July 19, 2005 143:151

  • High-Dosage Vitamin E Supplementation and All-Cause Mortality

    • Harri Hemilä
    Ann Intern Med July 19, 2005 143:151-152

  • High-Dosage Vitamin E Supplementation and All-Cause Mortality

    • Wee-Shiong Lim,
    • Rajka Liscic,
    • Chengjie Xiong,
    • and John C. Morris
    Ann Intern Med July 19, 2005 143:152

  • High-Dosage Vitamin E Supplementation and All-Cause Mortality

    • Connie Marras,
    • Anthony E. Lang,
    • David Oakes,
    • Michael P. McDermott,
    • Karl Kieburtz,
    • Ira Shoulson,
    • Caroline M. Tanner,
    • and Stanley Fahn
    Ann Intern Med July 19, 2005 143:152-153

  • High-Dosage Vitamin E Supplementation and All-Cause Mortality

    • Simin Nikbin Meydani,
    • Joseph Lau,
    • Gerard E. Dallal,
    • and Mohsen Meydani
    Ann Intern Med July 19, 2005 143:153

  • High-Dosage Vitamin E Supplementation and All-Cause Mortality

    • Kent J. DeZee,
    • William Shimeall,
    • Kevin Douglas,
    • and Jeffrey L. Jackson
    Ann Intern Med July 19, 2005 143:153-154

  • High-Dosage Vitamin E Supplementation and All-Cause Mortality

    • Antonio M. Possolo
    Ann Intern Med July 19, 2005 143:154

  • High-Dosage Vitamin E Supplementation and All-Cause Mortality

    • Ishwarlal Jialal and
    • Sridevi Devaraj
    Ann Intern Med July 19, 2005 143:155

  • High-Dosage Vitamin E Supplementation and All-Cause Mortality

    • Thomas Carter
    Ann Intern Med July 19, 2005 143:155

  • High-Dosage Vitamin E Supplementation and All-Cause Mortality

    • Joseph E. Baggott
    Ann Intern Med July 19, 2005 143:155-156

  • High-Dosage Vitamin E Supplementation and All-Cause Mortality

    • Edgar R. Miller III,
    • Lawrence J. Appel,
    • Eliseo Guallar,
    • and Roberto Pastor-Barriuso
    Ann Intern Med July 19, 2005 143:156-158

  • Report of Specific Cardiovascular Outcomes of the ADVANTAGE Trial

    • Ned Braunstein and
    • Adam Polis
    Ann Intern Med July 19, 2005 143:158-159

  • Myocarditis from the Chinese Sumac Tree

    • John D. Bisognano,
    • Kevin S. McGrody,
    • and Abraham M. Spence
    Ann Intern Med July 19, 2005 143:159-160

  • Correction: A New Concept of Unopposed β-Adrenergic Overstimulation in a Patient with Pheochromocytoma

    Ann Intern Med July 19, 2005 143:160

Current Clinical Issues

  • Gene Therapy Yields to RNA Interference

    • Jennifer Fisher Wilson
    Ann Intern Med July 19, 2005 143:161-164

Ad Libitum

Medical Notices

  • Medical Notices

    Ann Intern Med July 19, 2005 143:0

Summaries for Patients

  • The Cost-Effectiveness of Full Medicare Coverage of Angiotensin-Converting Enzyme Inhibitors for Patients with Diabetes

    Ann Intern Med July 19, 2005 143:I-21

  • Estimating the Probability of Deep Venous Thrombosis in Outpatients

    Ann Intern Med July 19, 2005 143:I-27

  • How Common Is Silent Heart Disease in the Relatives of Patients with Heart Failure?

    Ann Intern Med July 19, 2005 143:I-28

  • High Vitamin E Intake among U.S. Adults

    Ann Intern Med July 19, 2005 143:I-39

  • Clinical Diagnosis of Deep Venous Thrombosis

    Ann Intern Med July 19, 2005 143:I-40
« Previous | Next Issue »

This Issue

July 19, 2005; 143 (2)
  1. Articles
  2. Improving Patient Care
  3. Review
  4. Editorials
  5. On Being a Doctor
  6. Letters
  7. Current Clinical Issues
  8. Ad Libitum
  9. Medical Notices
  10. Summaries for Patients

Search in this issue:

Current Issue

  1. November 3, 2009, 151 (9)
  1. Alert me to current issues